Remcyta 500mg Injection
By Remcyta
Rx
1 Injection in a Vial

Composition
Cytarabine(500mg)

Manufacturer - Alkem Laboratories Ltd
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.

Expires on or after
July, 2025

liver
Limited information exists regarding the use of Remcyta 500mg Injection in individuals with liver conditions. Hence, it is strongly advised to seek guidance from your healthcare provider. Due to the lack of extensive data, it is recommended to exercise caution when utilizing Remcyta 500mg Injection in patients with liver issues.

kidney
Remcyta 500mg Injection is safe for patients with kidney disease without needing a dose adjustment. It is still important to inform your doctor about any existing kidney conditions.

alcohol
Consult your doctor when consuming alcohol with Remcyta 500mg Injection.

driving
Remcyta 500mg Injection may cause side effects impacting driving ability.

pregnancy
Remcyta 500mg Injection is considered unsafe during pregnancy due to potential risks to the developing baby. However, in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor.

breastfeeding
Remcyta 500mg Injection is not recommended for use while breastfeeding as it may cause toxicity to the baby. It is better to consult your doctor before using Remcyta 500mg Injection.
Habit Forming | No |
Chemical Class | Pyrimidine Nucleoside Analogue |
Therapeutic Class | ANTI NEOPLASTICS |
Action Class | Antimetabolites |
₹541.31
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024